downslanting wedge, page-5

The price is certainly at a critical level. But with the whole sector running out of puff I think further slides will accelerate as people "lock in" some profits.

This about it this way:

Many people out there bought in under $1. They all believe the stock is worth $10 and hold even after it hits $3. The stock starts to slide and as it approches theiur buy price they get nervous. Their optimism turns to a "i feel stupid for not selling at $3" feeling. They then proceed to sell.

Someone always posts here about gaps being filled. I'm a believer in that policy for biotechs (unless the actually get something material). VCR still has no approval and have tested the device of two patients. But the stock is about triple what it was a few months back.

I'm expecting to see the $1.80-$2.20 level soon.